Home/Filings/8-K/0001193125-26-012259
8-K//Current report

Perspective Therapeutics, Inc. 8-K

Accession 0001193125-26-012259

$CATXCIK 0000728387operating

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 7:00 AM ET

Size

11.0 MB

Accession

0001193125-26-012259

Research Summary

AI-generated summary of this filing

Updated

Perspective Therapeutics Files Updated Corporate Presentation (8-K)

What Happened
Perspective Therapeutics, Inc. (CATX) filed a Current Report on Form 8-K on January 14, 2026 (Item 8.01) to disclose an updated corporate presentation. A copy of the presentation is attached as Exhibit 99.1 and is incorporated by reference into the filing. The report was signed by Joel Sendek, Chief Financial Officer.

Key Details

  • Filing date: January 14, 2026.
  • Event type: Item 8.01 — Other events (updated corporate presentation).
  • Exhibit included: 99.1 — Corporate Presentation (also referenced in Item 9.01).
  • No financial results, earnings, executive departures, mergers, or other material corporate actions were reported in this filing.

Why It Matters
Updated corporate presentations can provide refreshed information on strategy, clinical programs, timelines, or investor priorities that may affect investor understanding of the company. This 8-K does not report earnings or other material financial changes; investors should review Exhibit 99.1 directly for any new program updates or timelines disclosed by management.

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000728387

Filing Metadata

Form type
8-K
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:00 AM ET
Size
11.0 MB